Evidence map›Paper›PMID 11574613›Full record

ArticleJournal of clinical microbiology2001

Evaluation of BACTEC MGIT 960 and BACTEC 460TB systems for recovery of mycobacteria from clinical specimens of a university hospital with low incidence of tuberculosis.

L Leitritz, S Schubert, B Bücherl, A Masch, J Heesemann, A Roggenkamp

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Advances in TB testing.Advances in clinical chemistry · 2023
    Article
  4. Review
  5. Article
  6. Failure of BACTEC™ MGIT 960™ to detectAfrican journal of laboratory medicine · 2017
    Article
  7. Article
  8. Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2015
    Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

L LeitritzMax von Pettenkofer-Institut, 80336 Munich, Germany. lorenz.leitritz@mvp.med.uni-muenchen.de
S Schubert
B Bücherl
A Masch
J Heesemann
A Roggenkamp

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical samples obtained over a period of 8 months (n = 2,624) were processed in parallel with the BACTEC 460TB system, with the MGIT 960 system, and in Löwenstein-Jensen (LJ) medium, resulting in the recovery of 127 mycobacteria. Recovery rates in combinations of the BACTEC 460TB or MGIT 960 system with LJ were, respectively, 94.7 and 94.7% for Mycobacterium tuberculosis complex (n = 57) and 91.4 and 70.0% for nontuberculous mycobacteria (n = 70). Contamination rates, elevated in the MGIT 960 system, were associated with patients (cystic fibrosis) and type of material but not with transport time. Detection time was reduced in the MGIT 960 system.

Indexed as

Hospitals, UniversityBacteriological TechniquesCulture MediaHumansIncidenceMycobacteriumMycobacterium InfectionsTuberculosisCulture Media

Identifiers

PMID11574613
PMCPMC88429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.